These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 20451694

  • 1. Effect of obesity on left ventricular mass and systolic function in patients with asymptomatic aortic stenosis (a Simvastatin Ezetimibe in Aortic Stenosis [SEAS] substudy).
    Lund BP, Gohlke-Bärwolf C, Cramariuc D, Rossebø AB, Rieck AE, Gerdts E.
    Am J Cardiol; 2010 May 15; 105(10):1456-60. PubMed ID: 20451694
    [Abstract] [Full Text] [Related]

  • 2. Low-flow aortic stenosis in asymptomatic patients: valvular-arterial impedance and systolic function from the SEAS Substudy.
    Cramariuc D, Cioffi G, Rieck AE, Devereux RB, Staal EM, Ray S, Wachtell K, Gerdts E.
    JACC Cardiovasc Imaging; 2009 Apr 15; 2(4):390-9. PubMed ID: 19580719
    [Abstract] [Full Text] [Related]

  • 3. Impact of hypertension on left ventricular structure in patients with asymptomatic aortic valve stenosis (a SEAS substudy).
    Rieck AE, Cramariuc D, Staal EM, Rossebø AB, Wachtell K, Gerdts E.
    J Hypertens; 2010 Feb 15; 28(2):377-83. PubMed ID: 19844185
    [Abstract] [Full Text] [Related]

  • 4. Factors influencing left ventricular structure and stress-corrected systolic function in men and women with asymptomatic aortic valve stenosis (a SEAS Substudy).
    Cramariuc D, Rieck AE, Staal EM, Wachtell K, Eriksen E, Rossebø AB, Gerdts E.
    Am J Cardiol; 2008 Feb 15; 101(4):510-5. PubMed ID: 18312768
    [Abstract] [Full Text] [Related]

  • 5. Hypertension in aortic stenosis: implications for left ventricular structure and cardiovascular events.
    Rieck ÅE, Cramariuc D, Boman K, Gohlke-Bärwolf C, Staal EM, Lønnebakken MT, Rossebø AB, Gerdts E.
    Hypertension; 2012 Jul 15; 60(1):90-7. PubMed ID: 22647889
    [Abstract] [Full Text] [Related]

  • 6. Relation of Left Ventricular Mass to Prognosis in Initially Asymptomatic Mild to Moderate Aortic Valve Stenosis.
    Gerdts E, Rossebø AB, Pedersen TR, Cioffi G, Lønnebakken MT, Cramariuc D, Rogge BP, Devereux RB.
    Circ Cardiovasc Imaging; 2015 Nov 15; 8(11):e003644; discussion e003644. PubMed ID: 26489804
    [Abstract] [Full Text] [Related]

  • 7. Asymmetric septal hypertrophy - a marker of hypertension in aortic stenosis (a SEAS substudy).
    Tuseth N, Cramariuc D, Rieck AE, Wachtell K, Gerdts E.
    Blood Press; 2010 Jun 15; 19(3):140-4. PubMed ID: 20429691
    [Abstract] [Full Text] [Related]

  • 8. Impact of Obesity on Persistent Left Ventricular Hypertrophy After Aortic Valve Replacement for Aortic Stenosis.
    Einarsen E, Saeed S, Cramariuc D, Chambers JB, Midtbø H, Gerdts E.
    Am J Cardiol; 2019 Mar 15; 123(6):942-947. PubMed ID: 30654925
    [Abstract] [Full Text] [Related]

  • 9. Left atrial size and function as predictors of new-onset of atrial fibrillation in patients with asymptomatic aortic stenosis: the simvastatin and ezetimibe in aortic stenosis study.
    Bang CN, Dalsgaard M, Greve AM, Køber L, Gohlke-Baerwolf C, Ray S, Rossebø AB, Egstrup K, Wachtell K.
    Int J Cardiol; 2013 Oct 03; 168(3):2322-7. PubMed ID: 23416018
    [Abstract] [Full Text] [Related]

  • 10. Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study.
    Rossebø AB, Pedersen TR, Allen C, Boman K, Chambers J, Egstrup K, Gerdts E, Gohlke-Bärwolf C, Holme I, Kesäniemi VA, Malbecq W, Nienaber C, Ray S, Skjaerpe T, Wachtell K, Willenheimer R.
    Am J Cardiol; 2007 Apr 01; 99(7):970-3. PubMed ID: 17398194
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Left ventricular midwall mechanics in subjects with aortic stenosis and normal systolic chamber function.
    Ballo P, Mondillo S, Motto A, Faraguti SA.
    J Heart Valve Dis; 2006 Sep 01; 15(5):639-50. PubMed ID: 17044369
    [Abstract] [Full Text] [Related]

  • 13. Effect of overweight and obesity on cardiovascular events in asymptomatic aortic stenosis: a SEAS substudy (Simvastatin Ezetimibe in Aortic Stenosis).
    Rogge BP, Cramariuc D, Lønnebakken MT, Gohlke-Bärwolf C, Chambers JB, Boman K, Gerdts E.
    J Am Coll Cardiol; 2013 Oct 29; 62(18):1683-1690. PubMed ID: 23770175
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Impact of pressure recovery on echocardiographic assessment of asymptomatic aortic stenosis: a SEAS substudy.
    Bahlmann E, Cramariuc D, Gerdts E, Gohlke-Baerwolf C, Nienaber CA, Eriksen E, Wachtell K, Chambers J, Kuck KH, Ray S.
    JACC Cardiovasc Imaging; 2010 Jun 29; 3(6):555-62. PubMed ID: 20541709
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of lipid lowering on new-onset atrial fibrillation in patients with asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study.
    Bang CN, Greve AM, Boman K, Egstrup K, Gohlke-Baerwolf C, Køber L, Nienaber CA, Ray S, Rossebø AB, Wachtell K.
    Am Heart J; 2012 Apr 29; 163(4):690-6. PubMed ID: 22520536
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.